
Betulinic Acid Market Report 2026
Global Outlook – By Type (Natural Extracted Betulinic Acid, Synthetic Betulinic Acid), By Purity (Up To 95 Percent, Above 95 Percent), By Application (Pharmaceutical, Cosmetics And Personal Care, Nutraceuticals, Other Applications), By End-User (Pharmaceutical Companies, Cosmetic Companies) – Market Size, Trends, Strategies, and Forecast to 2035
Betulinic Acid Market Overview
• Betulinic Acid market size has reached to $1.45 billion in 2025 • Expected to grow to $2.69 billion in 2030 at a compound annual growth rate (CAGR) of 13.2% • Growth Driver: Increasing Research And Development Spending In Pharmaceutical Drug Discovery Is Fueling The Growth Of The Market Due To Rising Innovation In Drug Development And Demand For Advanced Therapeutic Solutions • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Betulinic Acid Market?
Betulinic acid is a naturally occurring pentacyclic triterpenoid compound primarily derived from the bark of certain trees, especially birch species. It is known for its diverse biological properties, including anti-inflammatory, antiviral, and anticancer activities. The compound is widely studied for its potential therapeutic applications and is used in pharmaceutical and biochemical research. The main types of betulinic acid include natural extracted betulinic acid and synthetic betulinic acid. Natural extracted betulinic acid refers to bioactive compounds derived from plant sources such as birch bark, known for their therapeutic and biofunctional properties. These products are categorized by purity levels including up to 95 percent and above 95 percent. The various applications involved are pharmaceutical, cosmetics and personal care, nutraceuticals, and others, and they are used by several end users such as pharmaceutical companies and cosmetic companies.
What Is The Betulinic Acid Market Size and Share 2026?
The betulinic acid market size has grown rapidly in recent years. It will grow from $1.45 billion in 2025 to $1.64 billion in 2026 at a compound annual growth rate (CAGR) of 12.9%. The growth in the historic period can be attributed to traditional use of plant-derived compounds in herbal medicine systems, growing pharmaceutical interest in natural product screening, increasing prevalence of chronic diseases driving drug discovery research, expansion of botanical extraction technologies, rising academic research in triterpenoid chemistry.What Is The Betulinic Acid Market Growth Forecast?
The betulinic acid market size is expected to see rapid growth in the next few years. It will grow to $2.69 billion in 2030 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to expansion of precision medicine and targeted cancer therapies, increasing investment in natural compound-based drug development, growth in antiviral and immunotherapy research, rising demand for bioactive nutraceutical ingredients, advancements in synthetic biology and compound optimization techniques. Major trends in the forecast period include increased research on betulinic acid as a potential anticancer and antiviral therapeutic compound, growing use of plant-derived triterpenoids in pharmaceutical drug discovery pipelines, expansion of natural bioactive compounds in nutraceutical formulations, rising adoption of botanical extracts in dermatology and cosmetic anti-inflammatory products, increasing focus on semi-synthetic modification of betulinic acid for enhanced bioavailability and efficacy.Global Betulinic Acid Market Segmentation
1) By Type: Natural Extracted Betulinic Acid, Synthetic Betulinic Acid 2) By Purity: Up To 95 Percent, Above 95 Percent 3) By Application: Pharmaceutical, Cosmetics And Personal Care, Nutraceuticals, Other Applications 4) By End-User: Pharmaceutical Companies, Cosmetic Companies Subsegments: 1) By Natural Extracted Betulinic Acid: Plant Derived Betulinic Acid, Bark Extracted Betulinic Acid, Leaf Extracted Betulinic Acid, Herbal Source Betulinic Acid 2) By Synthetic Betulinic Acid: Chemically Synthesized Betulinic Acid, Semi Synthetic Betulinic Acid, High Purity Laboratory Synthesized Betulinic Acid, Industrial Grade Synthetic Betulinic Acid, Pharmaceutical Grade Synthetic Betulinic AcidWhat Are The Drivers Of The Betulinic Acid Market?
The increasing research and development spending in pharmaceutical drug discovery is expected to propel the growth of the betulinic acid market going forward. Research and development spending in pharmaceutical drug discovery refers to financial investments made by companies and institutions to develop new drugs, therapies, and treatment solutions. The rise in increasing research and development spending in pharmaceutical drug discovery due to growing demand for advanced and targeted therapies is driving innovation in drug development. Research and development spending in pharmaceutical drug discovery for betulinic acid is used to optimize its chemical properties, improve bioavailability, and validate its safety and efficacy for applications such as anticancer and antiviral therapies. For instance, in January 2024, according to the Food and Drug Administration, a US-based government agency, 55 novel drugs were approved in 2023 compared to 37 in 2022, with 36% classified as first-in-class therapies and over 50% targeting rare diseases. Therefore, the increasing research and development spending in pharmaceutical drug discovery is driving the growth of the betulinic acid industry. The increasing prevalence of cancer is expected to propel the growth of the betulinic acid market going forward. Cancer refers to a group of diseases characterized by uncontrolled cell growth that can spread to other parts of the body and require therapeutic intervention. The rise in increasing prevalence of cancer due to growing ageing population is driving higher incidence rates globally. Betulinic acid supports this demand by offering potential anticancer properties that contribute to research and development of novel therapeutic treatments. For instance, in October 2025, according to the Cancer Research UK, a UK-based independent cancer research organization, cancer incidence in the UK is projected to grow at approximately 2% between 2024–2026 and 2038–2040, reaching over 505,000 new cases annually by the end of the forecast period. Therefore, the increasing prevalence of cancer is driving the growth of the betulinic acid industry. The growing use in cosmetics and skincare is expected to propel the growth of the betulinic acid market going forward. Cosmetics and skincare refer to products designed for cleansing, protecting, and enhancing the appearance and health of the skin through active ingredients and formulations. The increasing demand for natural and plant-based skincare products, driven by rising consumer awareness regarding clean-label ingredients and skin health, is accelerating the adoption of bioactive compounds in formulations. Betulinic acid supports this demand by offering anti-inflammatory, antioxidant, and skin-repair properties, making it a valuable ingredient in anti-aging creams, serums, and dermatological products. For instance, in June 2025, according to the Cosmetic, Toiletry and Perfumery Association (CTPA), a UK-based trade association, in 2024, the toiletries and beauty sector recorded sales of $13.9 billion (£10.3 billion), reflecting a robust year-on-year growth of 8.4%. Therefore, the growing use in cosmetics and skincare is driving the growth of the betulinic acid industry.Key Players In The Global Betulinic Acid Market
Major companies operating in the betulinic acid market are Symrise BioActives GmbH, Purestar Chem Enterprise Co. Ltd., Cayman Chemical, Tokyo Chemical Industry Co. Ltd., Santa Cruz Biotechnology Inc., MedChemExpress, Leap Chem Co. Ltd., H&Z Industry Co. Ltd., Finetech Industry Limited, Aktin Chemicals Inc., BOC Sciences, Manus Aktteva Biopharma LLP, Hangzhou Lingrui Chemical Co. Ltd., Capot Chemical Co. Ltd., Kono Chem Co. Ltd., Glentham Life Sciences Ltd., Xiamen Hisunny Chemical Co. Ltd., Dayang Chem (Hangzhou) Co. Ltd., BIOZOL Diagnostica Vertrieb GmbH, Wuhan PharmChem Co. Ltd., Betulin Lab, Shanghai Tauto Biotech Co. Ltd., DaXingAnLing Lingonberry Boreal Biotech, Simagchem Corporation, Sancai Industry Co. Ltd.Regional Outlook/Insights
North America was the largest region in the betulinic acid market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Betulinic Acid Market?
The betulinic acid market consists of sales of naturally derived triterpenoid compounds, purified extracts, and formulated products. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Betulinic Acid Market Report 2026?
The betulinic acid market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the betulinic acid industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Betulinic Acid Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $1.64 billion |
| Revenue Forecast In 2035 | $2.69 billion |
| Growth Rate | CAGR of 13.2% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Type, Purity, Application, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | Symrise BioActives GmbH, Purestar Chem Enterprise Co. Ltd., Cayman Chemical, Tokyo Chemical Industry Co. Ltd., Santa Cruz Biotechnology Inc., MedChemExpress, Leap Chem Co. Ltd., H&Z Industry Co. Ltd., Finetech Industry Limited, Aktin Chemicals Inc., BOC Sciences, Manus Aktteva Biopharma LLP, Hangzhou Lingrui Chemical Co. Ltd., Capot Chemical Co. Ltd., Kono Chem Co. Ltd., Glentham Life Sciences Ltd., Xiamen Hisunny Chemical Co. Ltd., Dayang Chem (Hangzhou) Co. Ltd., BIOZOL Diagnostica Vertrieb GmbH, Wuhan PharmChem Co. Ltd., Betulin Lab, Shanghai Tauto Biotech Co. Ltd., DaXingAnLing Lingonberry Boreal Biotech, Simagchem Corporation, Sancai Industry Co. Ltd. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
